E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/11/2020 in the Prospect News Convertibles Daily.

New Issue: Qiagen prices upsized $500 million seven-year convertible notes to yield 0%, up 55%

By Abigail W. Adams

Portland, Me., Dec. 11 – Qiagen NV priced an upsized $500 million seven-year convertible notes at par to yield 0% with an initial conversion premium of 55%, according to a company news release.

Pricing came at the cheap end of talk for an offer price of par to 102 to yield 0% to negative 0.28% and at the rich end of talk for an initial conversion premium of 45% to 55%, according to a market source.

Goldman Sachs International, Deutsche Bank, and BofA Securities are joint global coordinators and bookrunners for the Regulation S offering.

BNP Paribas, HSBC and UniCredit Bank are also joint bookrunners.

The initial size of the offering was $450 million.

The bonds are contingently convertible until June 17, 2026.

The convertibles are non-callable for five years and then subject to a 130% hurdle.

The notes are putable on Dec. 17, 2025 or upon a fundamental change or delisting event.

Upon conversion, the bonds will be settled in cash, shares or a combination of both at the company’s option.

Proceeds will be used to repurchase $172.8 million of the principal amount of the company’s 0.875% convertible notes due 2021, to settle warrants related to the 2021 notes and for general corporate purposes.

Qiagen is a Venlo, Netherlands-based molecular diagnostics company.

Issuer:Qiagen NV
Securities:Convertible notes
Amount:$500 million
Maturity:Dec. 17, 2027
Bookrunners:Goldman Sachs International, Deutsche Bank, BofA Securities, BNP Paribas, HSBC and UniCredit Bank
Coupon:0%
Price:Par
Yield:0%
Conversion premium:55%
Conversion price:$80.7218
Call options:Non-callable for five years and then subject to a 130% hurdle
Put options:On Dec. 17, 2025 or upon a change-of-control or delisting event
Pricing date:Dec. 11
Settlement date:Dec. 17
Distribution:Regulation S
Talk:Par to 102 to yield 0% to negative 0.28% and initial conversion premium of 45% to 55%
Stock symbol:NYSE: QGEN
Stock price:$52.0786 VWAP on Dec. 10
Market capitalization:$11.88 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.